ALTHEA GROUP HOLDINGS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.033 AUD | +10.00% |
|
+6.45% | -15.38% |
| Apr. 22 | Althea Group Signs Distribution Agreement with Symbion | MT |
| Feb. 29 | Althea Group Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Sales 2022 | 20.52M 13.31M | Sales 2023 | 25.09M 16.28M | Capitalization | 16.4M 10.64M |
|---|---|---|---|---|---|
| Net income 2022 | -12M -7.79M | Net income 2023 | -13M -8.43M | EV / Sales 2022 | 0.86 x |
| Net cash position 2022 | 1.07M 693K | Net Debt 2023 | 978K 635K | EV / Sales 2023 | 0.69 x |
| P/E ratio 2022 |
-1.48
x | P/E ratio 2023 |
-1.1
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.76% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -3.23% | ||
| 1 week | -6.25% | ||
| Current month | -6.25% | ||
| 1 month | -6.25% | ||
| 3 months | -23.08% | ||
| 6 months | -25.00% | ||
| Current year | -23.08% |
1 week
0.03
0.03
1 month
0.030.03
Current year
0.030.04
1 year
0.030.06
3 years
0.030.49
5 years
0.031.45
10 years
0.031.45
| Managers | Title | Age | Since |
|---|---|---|---|
Joshua Fegan
FOU | Founder | 39 | 17-06-20 |
| Director of Finance/CFO | 43 | 18-10-14 | |
Patty Holmes
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Alan M. Boyd
BRD | Director/Board Member | - | - |
Andrew Newbold
CHM | Chairman | - | - |
Joshua Fegan
FOU | Founder | 39 | 17-06-20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 0.033 | +10.00% | 18 349 |
| 24-04-22 | 0.03 | -3.23% | 337,875 |
| 24-04-19 | 0.031 | +3.33% | 42,590 |
| 24-04-18 | 0.03 | -3.23% | 29,681 |
| 24-04-17 | 0.031 | -3.13% | 11,764 |
Delayed Quote Australian S.E., April 22, 2024 at 12:50 am EDT
More quotes
Althea Group Holdings Limited is engaged in the manufacturing, sales and distribution of recreational cannabis products and cannabis-based medicines. The Company operates through three business units: Althea, MyAccess Clinics and Peak Processing Solutions. Althea and MyAccess Clinics service the international pharmaceutical cannabis market, whilst Peak Processing Solutions operates in the federally legal Canadian recreational cannabis market. The Companyâs segments include the international pharmaceutical segment (Pharmaceutical Cannabis), the Canadian recreational segment (Recreational Cannabis) and the shared corporate services (Corporate). The Pharmaceutical Cannabis includes Althea, a brand of cannabis-based medicine. The Companyâs Recreational Cannabis segment includes Peak Processing Solutions (Peak), a contract manufacturing organization which works with consumer-packaged goods companies to develop, manufacture, and distribute recreational cannabis products.
Sector
Pharmaceuticals
Calendar
2024-08-28
- Q4 2024 Earnings Release (Projected)
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.08% | 7.92M | |
| +27.92% | 659B | |
| +27.68% | 557B | |
| -4.59% | 359B | |
| +16.38% | 322B | |
| +9.39% | 297B | |
| +6.30% | 215B | |
| +4.80% | 210B | |
| -6.05% | 200B | |
| -8.58% | 149B |
- Stock Market
- Equities
- AGH Stock
